Site Search

IMI1 – Call 5 was launched on 6 March 2012 with the following theme: European lead factory This Call theme consists of two topics: European screening centre Joint European compound collection More information on the topics can be found in IMI’s press release and in the Call text ...

IMI1 – Call 4 was launched on 18 July 2011 with the following topics: A European medical information framework (EMIF) of patient-level data to support a wide range of medical research This Call theme consists of three topics: Information framework / knowledge management service ...

IMI1 – Call 3 was launched on 22 October 2010 with the following topics: Improving the early prediction of drug induced liver injury in man Immunogenicity: assessing the clinical relevance and risk minimization of antibodies to biopharmaceuticals Immunosafety of vaccines – new ...

IMI1 – Call 2 was launched on 27 November 2009 with the following topics: New tools for target validation to improve drug efficacy Molecular biomarkers - accelerating cancer therapy development and refining patient care Imaging biomarkers for anticancer drug development ...

IMI1 – Call 1 was launched on 30 April 2008 with the following topics: Improve predictivity of immunogenicity Non-genotoxic carcinogenesis Expert systems for in silico toxicity prediction Improved predictivity of non-clinical safety evaluation Qualification of translational ...

Our mission At the Innovative Medicines Initiative (IMI), we are working to improve health by speeding up the development of, and patient access to, innovative medicines, particularly in areas where there is an unmet medical or social need. We do this by facilitating ...

The Innovative Medicines Initiative (IMI) is funded jointly by the European Union (represented by the European Commission) and the European pharmaceutical industry (represented by EFPIA, the European Federation of Pharmaceutical Industries and Associations). Details of who ...

This page explains how our top level objectives, as set out in the IMI1 and IMI2 legislation and the Strategic Research Agenda guide the choice of topics for Calls for proposals and, ultimately, the selection of projects. From top level objectives to annual priorities Our top ...

Be a part of the IMI story Want to be a part of the IMI story? Visit the Get involved section of our website and find out how you can benefit from and contribute to our work Sowing the seeds – the European Technology Platform on Innovative Medicines (2005-2009) The origins of the ...